XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Total revenues $ 216,033 $ 208,976 $ 599,214 $ 478,620
Operating expenses        
Cost of sales 54,823 47,319 140,063 97,184
Amortization of intangibles 20,341 27,193 56,011 38,596
Research and development 17,321 16,705 55,027 44,041
Selling, general and administrative 35,269 34,467 111,574 105,777
Total operating expenses 127,754 125,684 362,675 285,598
Operating income 88,279 83,292 236,539 193,022
Other income (expense)        
Investment and other income, net 4,786 641 10,957 194
Inducement expense related to convertible notes 0 (2,712) 0 (2,712)
Contingent liability fair value measurement gain 13,200 0 13,200 0
Interest expense (4,505) (7,514) (13,542) (12,377)
Net income before income taxes 101,760 73,707 247,154 178,127
Income tax expense 19,923 12,073 50,948 33,700
Net income $ 81,837 $ 61,634 $ 196,206 $ 144,427
Earnings per share        
Basic (USD per share) $ 0.62 $ 0.45 $ 1.48 $ 1.05
Diluted (USD per share) $ 0.61 $ 0.44 $ 1.45 $ 1.02
Weighted average common shares outstanding        
Basic (shares) 131,965 136,527 132,896 137,370
Diluted (shares) 134,083 139,387 135,233 141,019
Royalties        
Revenues        
Total revenues $ 114,433 $ 99,551 $ 325,813 $ 254,496
Product sales, net        
Revenues        
Total revenues 86,569 61,427 221,252 129,867
Revenues under collaborative agreements        
Revenues        
Total revenues $ 15,031 $ 47,998 $ 52,149 $ 94,257